Search

Search Results

1. Mitotane

   in Reactions Weekly

   Article 20 June 2020

2. Hydrocortisone/mitotane

   in Reactions Weekly

   Article 20 June 2020

3. Mitotane

   in Reactions Weekly

   Article 25 April 2020

4. Massive adrenocortical carcinoma presenting as peripheral edema: a case report

   Background

   Adrenocortical carcinoma is a rare, but potentially lethal, malignancy that is usually detected as an incidental finding on abdominal...

   David A. Goodkin in Journal of Medical Case Reports

   Article Open access 20 June 2022
   

5. La strategia nell’uso del mitotane

   Anna Calabrese, Soraya Puglisi, ... Massimo Terzolo in L'Endocrinologo

   Article 01 May 2020
   

6. Gestione della terapia adiuvante con mitotane nei pazienti affetti da carcinoma corticosurrenalico

   Giuseppina De Filpo, Letizia Canu in L'Endocrinologo

   Article Open access 25 August 2020

7. Pregnancy in patients with adrenocortical carcinoma: a case-based discussion

   Although adrenocortical carcinoma (ACC) during pregnancy is rare, a retrospective review of a case series at our hospital revealed that almost one...

   Soraya Puglisi, Vittoria Basile, ... Massimo Terzolo in Reviews in Endocrine and Metabolic Disorders

   Article 22 November 2022
   

8. Mitotane

   in Reactions Weekly

   Article 04 January 2020

9. Ketoconazole/mitotane/pembrolizumab

   in Reactions Weekly

   Article 25 January 2020

10. Oncocytic adrenocortical neoplasm of borderline uncertain malignant potential diagnosed after robot-assisted adrenalectomy case report

    Background

    Adrenal incidentalomas are radiologically discovered tumors that represent a variety of pathologies, with the diagnosis clinched only on...

    Chih Peng Chin, Ralph Grauer, ... Ketan K. Badani in BMC Urology

    Article Open access 15 April 2023
    

11. Mitotane (Lysodren®) in der Therapie des Nebennierenrindenkarzinoms

    Mitotane, or o,p’-DDD (European tradename: Lysodren®, HRA Pharma, Paris, France), is an orphan drug for the adjuvant therapy of adrenocortical...

    Wolfgang Raber in Journal für Klinische Endokrinologie und Stoffwechsel

    Article Open access 12 August 2019
    

12. Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen

    Purpose

    The management of patients with advanced/metastatic adrenocortical carcinoma (ACC) is challenging, EDP-M (etoposide, doxorubicin, cisplatin...

    Antonella Turla, Marta Laganà, ... Alfredo Berruti in Endocrine

    Article Open access 14 May 2022
    

13. The effects of mitotane and 1α,25-dihydroxyvitamin D₃ on Wnt/beta-catenin signaling in human adrenocortical carcinoma cells

    Purpose

    Mitotane is the only chemotherapeutic agent available for the treatment of adrenocortical carcinoma (ACC), however, the anti-neoplastic...

    B. Rubin, C. Pilon, ... F. Fallo in Journal of Endocrinological Investigation

    Article 05 October 2019
    

14. High expression of GMNN predicts malignant progression and poor prognosis in ACC

    Background

    Adrenocortical carcinoma (ACC) is a rare endocrine neoplasm, which is characterized by poor prognosis and high recurrence rate. Novel and...

    **nzhao Zhao, Xuezhou Zhang, ... Yonghua Wang in European Journal of Medical Research

    Article Open access 20 December 2022
    

15. Mitotane

    in Reactions Weekly

    Article 19 October 2019

16. Mitotane

    in Reactions Weekly

    Article 14 September 2019

17. Challenges in the diagnosis of the enigmatic primary adrenal leiomyosarcoma: two case reports and review of the literature

    Background

    Primary adrenal leiomyosarcoma is a rare and aggressive mesenchymal tumor derived from the smooth muscle wall of a central adrenal vein or...

    Sawako Suzuki, Naoya Takahashi, ... Koutaro Yokote in BMC Endocrine Disorders

    Article Open access 18 December 2023
    

18. Cabergoline/ketoconazole/mitotane

    in Reactions Weekly

    Article 17 August 2019

19. Mitotane

    in Reactions Weekly

    Article 01 June 2019

20. Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future

    The introduction of Ki67 immunohistochemistry in the work-up of neuroendocrine neoplasms (NENs) has opened a new approach for their diagnosis and...

    Stefano La Rosa in Endocrine Pathology

    Article Open access 17 February 2023